No effect of aspirin on mammographic density in a randomized controlled clinical trial (Q37210539)

19 August 2017

No effect of aspirin on mammographic density in a randomized controlled clinical trial (English)

1 reference

19 August 2017

1 reference

9

John Potter

1 reference

19 August 2017

8

Mary Anne Rossing

1 reference

19 August 2017

5

Diana S M Buist

1 reference

19 August 2017

1

Anne McTiernan

1 reference

19 August 2017

C Y Wang

2

1 reference

19 August 2017

Bess Sorensen

3

1 reference

19 August 2017

Liren Xiao

4

1 reference

19 August 2017

Erin J Aiello Bowles

6

1 reference

19 August 2017

Emily White

7

1 reference

19 August 2017

Nicole Urban

10

1 reference

19 August 2017

1 May 2009

1 reference

Cancer Epidemiology, Biomarkers & Prevention

19 August 2017

1 reference

19 August 2017

18

1 reference

19 August 2017

5

1 reference

19 August 2017

1524-1530

1 reference

Mammographic density. Measurement of mammographic density

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

A randomized trial of aspirin to prevent colorectal adenomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Overview of the main outcomes in breast-cancer prevention trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Tamoxifen and mammographic breast densities

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Mammographic features and breast cancer risk: effects with time, age, and menopause status.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Alterations of the biological characteristics of a colon carcinoma cell line by colon-derived substrata material.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Mammographic density and estrogen receptor status of breast cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Tamoxifen and breast density in women at increased risk of breast cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Mammographic density and breast cancer in three ethnic groups

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Effects of mammographic density and benign breast disease on breast cancer risk (United States).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Effect of tamoxifen on mammographic density.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Nonsteroidal antiinflammatory drugs and breast cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689709

Physical activity and risk of lung cancer

3 September 2018

1 reference

12 December 2020

Growth arrest of DMBA-induced mammary carcinogenesis with ibuprofen treatment in female Sprague-Dawley rats

1 reference

12 December 2020

Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens

1 reference

12 December 2020

Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas

1 reference

12 December 2020

Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study

1 reference

12 December 2020

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

1 reference

12 December 2020

Prospective breast cancer risk prediction model for women undergoing screening mammography

1 reference

12 December 2020

Mammographic Density and the Risk and Detection of Breast Cancer

1 reference

12 December 2020

Mammographic densities and breast cancer risk

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs (NSAIDs) and mammographic density

1 reference

12 December 2020

10.1158/1055-9965.EPI-08-1088

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference